StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note published on Monday morning. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
CO opened at $1.00 on Monday. The stock has a 50-day moving average price of $1.21 and a 200-day moving average price of $1.34. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50. The stock has a market capitalization of $121.55 million, a P/E ratio of 1.56 and a beta of 0.16.
Global Cord Blood Company Profile
Further Reading
- Five stocks we like better than Global Cord Blood
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Conference Calls and Individual Investors
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.